相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Technetium-99m-or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma
Ximena Carnacho et al.
ONCOLOGY (2017)
Follow-up FDG PET/CT in Patients With Non-Hodgkin Lymphoma
Mehdi Taghipour et al.
CLINICAL NUCLEAR MEDICINE (2016)
Hybrid tracers and devices for intraoperative imaging: the future for radioguided surgery?
Juan Pablo Gambini et al.
CLINICAL AND TRANSLATIONAL IMAGING (2016)
Radiolabelling rituximab with 99mTc in three steps procedure
Charlotte Fontan et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2015)
99mTc carbonyl DTPA-Rituximab: Preparation and preliminary bioevaluation
Usha Pandey et al.
APPLIED RADIATION AND ISOTOPES (2014)
Role of PET in Lymphoma
Andrea Gallamini et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2014)
Enhancement of Rituximab-induced cell death by the physical association of CD20 with CD40 molecules on the cell surface
Loubna Al-Zoobi et al.
INTERNATIONAL IMMUNOLOGY (2014)
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Sally F. Barrington et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Microwave-assisted Synthesis of HYNIC Protected Analogue for Tc-99m Labeled Antibody
Maria F. Garcia et al.
CURRENT RADIOPHARMACEUTICALS (2014)
Synthesis and Evaluation of 99m Tc Chelate-conjugated Bevacizuma
Ximena Camacho et al.
CURRENT RADIOPHARMACEUTICALS (2013)
99mTc-labeled Rituximab for Imaging B Lymphocyte Infiltration in Inflammatory Autoimmune Disease Patients
G. Malviya et al.
MOLECULAR IMAGING AND BIOLOGY (2012)
Radiolabeling of rituximab with Re-188 and Tc-99m using the tricarbonyl technology
Carla Roberta Dias et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
Hydrazinonicotinic acid (HYNIC) - Coordination chemistry and applications in radiopharmaceutical chemistry
Levente K. Meszaros et al.
INORGANICA CHIMICA ACTA (2010)
Radioimmunotherapy of Lymphoma: Bexxar and Zevalin
Stanley J. Goldsmith
SEMINARS IN NUCLEAR MEDICINE (2010)
Renal uptake and metabolism of radiopharmaceuticals derived from peptides and proteins
Hiromichi Akizawa et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Near-infrared fluorescent labeled peptosome for application to cancer imaging
Hiroki Tanisaka et al.
BIOCONJUGATE CHEMISTRY (2008)
CD20 homo-oligomers physically associate with the B cell antigen receptor - Dissociation upon receptor engagement and recruitment of phosphoproteins and calmodulin-binding proteins
Maria J. Polyak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Evaluation of an 111In-Radiolabeled peptide as a targeting and Imaging agent for ErbB-2 receptor-expressing breast carcinomas
Senthil R. Kumar et al.
CLINICAL CANCER RESEARCH (2007)
Radioimmunotherapy as a therapeutic option for non-Hodgkin's lymphoma
Roger M. Macklis
SEMINARS IN RADIATION ONCOLOGY (2007)
Indication for different mechanisms of kidney uptake of radiolabeled peptides
Martin Gotthardt et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice
Zhen Cheng et al.
BIOCONJUGATE CHEMISTRY (2006)
Rituximab, an anti-CD20 monoclonal antibody: History and mechanism of action
MD Pescovitz
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Tc-99m-rituximab radiolabelled by photo-activation: a new non-Hodgkin's lymphoma imaging agent
TG Stopar et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
The therapeutic potential of anti-CD20 - What do B-cells do?
R Eisenberg et al.
CLINICAL IMMUNOLOGY (2005)
Radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin): The role of the nuclear medicine physician
PS Conti
SEMINARS IN NUCLEAR MEDICINE (2004)
Exploration of critical parameters for transient retrovirus production
MC Bajgelman et al.
JOURNAL OF BIOTECHNOLOGY (2003)
Anti-CD20-based therapy of B cell lymphoma: state of the art
C Kosmas et al.
LEUKEMIA (2002)
Metabolism and renal clearance of 111In-labeled DOTA-conjugated antibody fragments
SW Tsai et al.
BIOCONJUGATE CHEMISTRY (2001)
Labeling proteins with Tc-99m via hydrazinonicotinamide (HYNIC): Optimization of the conjugation reaction
HJJM Rennen et al.
NUCLEAR MEDICINE AND BIOLOGY (2000)
Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents
DJ Hawrysz et al.
NEOPLASIA (2000)
分享论文
